Egypt

Kahira Pharmaceuticals & Chemical Industries Co. S.A.E (القاهرة للأدوية والصناعات الكيماوية)

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Arabic Format: PDF Download Buy full report

What’s included?

This report extracts all available information about Kahira Pharmaceuticals & Chemical Industries Co. S.A.E from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Legal Address
4 Abd El-Hamed El-Deeb St.,Victoria Sguare, Shoubra,P.O Box 793
Cairo; Greater Cairo; Map

Tel: +20-2202,+20-2202
Fax: +20-2202

Email:
@kahirapharma.com.eg

Company Description
Kahira Pharmaceuticals was established in 1962 through the merger of leading laboratories. Kahira Pharmaceuticals is headquartered in Cairo and it is engaged in production and distribution of human and veterinary pharmaceuticals products, such as analgesics, antipyretics, antirheumatics, vitamins, antibiotics, eye and nasal drops. The company is engaged in the production of cosmetics and other chemical products as well. Kahira Pharmaceuticals exports its production to the Gulf countries, Africa, Kazakhstan, Romania, Russia and Ukraine.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
2,627 (2017)
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Incorporation Date:
1991
Profile Updated:
January 07, 2018
Key Executives
Director / Member of the Management Board
Director / Member of the Management Board
Director / Member of the Management Board
Director / Member of the Management Board
Director / Member of the Management Board
More
Ownership Details
Pharmaceuticals Holding Company
60%
Other
Key Financial Highlights
2018 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 753,735
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Financial Performance Charts

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO